Literature DB >> 24249316

Bilateral pulmonary embolism in twins with PAI-1 4G/5G gene polymorphism: a case report.

Andreas Kronbichler1, Peter Oelzner, Günter Syrbe, Eric Lopatta, Gunter Wolf, Thomas Neumann.   

Abstract

The aetiology of venous thromboembolism in adolescents is frequently associated with hereditary abnormalities of the coagulation system, autoimmune disorders or malignancies. The advent of specific laboratory tests has refined the identification of genetic traits. In this case report, we describe the occurrence of pulmonary embolism in young twins. Intensive tumour screening remained unremarkable. Evaluation of established risk factors for a clotting disorder remained negative, with the exception of a plasminogen activator inhibitor-1 4G/5G polymorphism. Despite the mild association accompanied by the presence of the 4G allele, this polymorphism might predispose to venous thromboembolism in some cases in general and in our case in particular.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24249316     DOI: 10.1007/s00508-013-0443-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  5 in total

Review 1.  Plasminogen activator inhibitor-1 levels and polymorphisms.

Authors:  Charles W Francis
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

2.  Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly.

Authors:  Tiny Hoekstra; Johanna M Geleijnse; Evert G Schouten; Frans J Kok; Cornelis Kluft
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-08       Impact factor: 4.222

Review 3.  The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.

Authors:  Argirios E Tsantes; Georgios K Nikolopoulos; Pantelis G Bagos; Stefanos Bonovas; Petros Kopterides; Georgios Vaiopoulos
Journal:  Thromb Res       Date:  2007-10-22       Impact factor: 3.944

Review 4.  Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.

Authors:  Mark W Gramling; Frank C Church
Journal:  Thromb Res       Date:  2010-01-15       Impact factor: 3.944

5.  Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.

Authors:  Argirios E Tsantes; Georgios K Nikolopoulos; Pantelis G Bagos; Evdoxia Rapti; Georgios Mantzios; Violeta Kapsimali; Anthi Travlou
Journal:  Thromb Haemost       Date:  2007-06       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.